COVID19 Prevention Care; A Cancer Specific Guideline (original) (raw)

COVID19 Prevention & Care; A Cancer Specific Guideline

Archives of Iranian Medicine, 2020

On March 11th 2020, the coronavirus outbreak was declared a pandemic by the WHO. One of the groups that is considered high risk in this pandemic are cancer patients as they are treated with a variety of immune system suppressor treatment modalities and this puts them in a great risk for infectious disease (including COVID-19). Therefore, cancer patients require higher level measures for preventing and treating infectious diseases. furthermore, cancer patients may bear additional risk due to the restriction of access to the routine diagnostic and therapeutic services during such epidemic. Since most of the attention of health systems is towards patients affected with COVID-19, the need for structured and unified approaches to COVID-19 prevention and care specific to cancer patients and cancer centers is felt more than ever. This article provides the recommendations and possible actions that should be considered by patients, their caregivers and families, physician, nurses, managers and staff of medical centers involved in cancer diagnosis and treatment. We pursued two major goals in our recommendations: first, limiting the exposure of cancer patients to medical environments and second, modifying the treatment modalities in a manner that reduces the probability of myelosuppression such as delaying elective diagnostic and therapeutic services, shortening the treatment course, or prolonging the interval between treatment courses.

Impact of the COVID-19 Pandemic on Cancer Patients: Challenges and Practical Approach to Management

Life and Science

The coronavirus 2019 (COVID-19) outbreak has rapidly spread worldwide, which poses great challenges to the healthcare system around the world. This pandemic has shown that globally medical community has no care- models to deal with the effects imposed on patients with chronic illnesses. Appropriate and timely diagnosis and treatment of this highly vulnerable immunocompromised population is mandatory. Prominent challenges faced during the current outbreak include resource allocation, management of patients suffering from and follow-up-phases, patient fear and protection of healthcare workers. During Pandemic, the major management strategies for cancer patients comprise education about personal protective measures, symptoms of COVID- 19, emotional support, clear communication about infection control measures and clinical care. To decrease the risk of exposure, active individualized cancer intervention is required with reduce outpatient visits and maximum telemedicine. Currently, inter...

Cancer Patients during COVID-19 Pandemic: A Mini-Review

Healthcare

Since its emergence, coronavirus disease 2019 (COVID-19) has affected the entire world and all commerce and industries, including healthcare systems. COVID-19 adversely affects cancer patients because they are immunocompromised. Increased COVID-19 infection and shortage of medical supplies, beds and healthcare workers in hospitals affect cancer care. This paper includes a description of the existing research that shows the impact of COVID-19 on the management of cancer patients. Aged people with various chronic conditions such as cancer and comorbidities face more challenges as they have a greater risk of disease severity. COVID-19 has affected care delivery, including patient management, and has been responsible for increased mortality among cancer patients. Cancer patients with severe symptoms require regular therapies and treatment; therefore, they have a higher risk of exposure. Due to the risk of transmission, various steps were taken to combat this disease; however, they have ...

Cancer Care Management During the COVID-19 Pandemic

Risk Management and Healthcare Policy

New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing around the world. Currently, health care services are mainly focused on responding to and controlling the unique challenges of the coronavirus disease 2019 (COVID-19) pandemic. These changes, along with the higher susceptibility of patients with cancer to infections, have profound effects on other critical aspects of care and pose a serious challenge for the treatment of such patients. During the COVID-19 pandemic, it is important to provide strategies for managing the treatment of patients with cancer to limit COVID-19-associated risks at this difficult time. The present study set out to summarize the latest research on epidemiology, pathogenesis, and clinical features of COVID-19. We also address some of the current challenges associated with the management of patients with cancer during the COVID-19 pandemic and provide practical guidance to clinically deal with these challenges.

Cancer treatment during COVID-19 pandemic

Medical Oncology

Currently world is fighting with global pandemic of coronavirus disease 2019 (COVID-19). At this time of uncertainty, oncologists are struggling to provide appropriate care to cancer patients. They have to weigh risk and benefit of giving cancer treatment vs chances of getting them infected with COVID-19. As cancer patients are immunocompromised and there are high chances of exposure during hospital visits and if they get infected, outcome can be fatal. So through the column of this article, we would like to provide basic guideline in management of cancer patients during COVID-19 pandemic.

Impact of the COVID-19 Outbreak on the Management of Patients with Cancer

Targeted Oncology

The coronavirus SARS-CoV-2 (COVID-19) outbreak is having a profound impact on the management of patients with cancer. In this review, we comprehensively investigate the various aspects of cancer care during the pandemic, taking advantage of data generated in Asia and Europe at the frontline of the COVID-19 pandemic spread. Cancer wards have been subjected to several modifications to protect patients and healthcare professionals from COVID-19 infection, while attempting to maintain cancer diagnosis, therapy, and research. In this setting, the management of COVID-19 infected patients with cancer is particularly challenging. We also discuss the direct and potential remote impacts of the global pandemic on the mortality of patients with cancer. As such, the indirect impact of the pandemic on the global economy and the potential consequences in terms of cancer mortality are discussed. As the infection is spreading worldwide, we are obtaining more knowledge on the COVID-19 pandemic consequences that are currently impacting and may continue to further challenge cancer care in several countries.

The Impact of the COVID-19 Pandemic on Cancer Patients

American Journal of Clinical Oncology, 2020

In December 2019, a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an outbreak of coronavirus disease 2019 (COVID-19). Severe complications have been reported to occur in 33% of patients with COVID-19 and include acute respiratory distress syndrome, acute renal failure, acute respiratory injury, septic shock, and severe pneumonia. Currently, there is no specific treatment or approved vaccine against COVID-19 and many clinical trials are currently investigating potential medications to treat COVID-19. The immunosuppressed status of some cancer patients (whether caused by the disease itself or the treatment) increases their risk of infection compared with the general population. This short review aims to focus on the impact of COVID-19 on a cancer patient and discuss management options and recommendation in addition to highlighting the currently available clinical guidelines and resources.

Treatment of Cancer Patients in the Era of the Covid-19 Pandemic

International journal of cancer and clinical research, 2022

Coronavirus Disease 2019 (COVID-19) is an outbreak of respiratory disease caused by novel coronavirus and has reached pandemic state. Cancer patients have increase susceptibility to infection caused by the malignancy itself and anticancer systemic therapy. Based on individual patient assessment, the oncologist's decision regarding the need for immediate oncological intervention classifies patients into 'urgent' and 'non-urgent' conditions. Consideration of risk and benefit for active intervention in the cancer population during an infectious disease pandemic must be individualized. Consideration for postponing elective surgery or chemotherapy for cancer patients with low risk of progression should be considered on a case-by-case basis. Options for treating or delaying treatment are best discussed with the patient in the context of multidisciplinary care.

Cancer Management Practices during the Novel Coronavirus Disease 2019 (COVID-19) Pandemic

Instant Journal of Hematology and Oncology

The COVID-19 pandemic has significantly impacted the management, treatment, and delivery of care to cancer patients. This impact has extended beyond patient care to include logistics, administration, and distribution of increasingly limited health care resources in cancer management healthcare institutions. Based on the collaborative experience of the management, administration, and medical staff at AL-Amal National Hospital (a tertiary health care institution delivering cancer management and treatment services in Baghdad, Iraq), measures were taken and recommendations were carefully formulated to safely proceed with therapy for cancer patients amid the current COVID-19 Pandemic. We hereby review and present AL-Amal National Hospital’s urgent plan to ensure that vital cancer services can still be delivered safely taking into consideration all the potential risks and benefits during this pandemic. Keywords: COVID-19; Coronavirus; SARS-CoV-2; Cancer